RxDoctor Payments Data

Steven Wahlen, MD

Radiation Oncology · Chico, CANPI 1457308769

Payments from drug & device makers

$1,969in general payments, 2019–2025

Across 11 payments — averaging $179.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Elekta, Inc.$1K
  • Boston Scientific$233
  • AstraZeneca$210
  • Zap Surgical Systems, Inc.$188
  • Progenics Pharmaceuticals, Inc.$118
  • Novocure Inc.$101
  • plus $69 from 1 others

What the payments were for

  • Travel & lodging$94848%
  • Food & beverage$1,02252%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Elekta, Inc.2$1,050
Boston Scientific2$233
AstraZeneca2$210
Zap Surgical Systems, Inc.2$188
Progenics Pharmaceuticals, Inc.1$118
Novocure Inc.1$101
Takeda Pharmaceuticals U.S.A., Inc.1$69

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,969 in reported general payments places this provider in the 70th percentile of 627 radiation oncology providers in California.

See all radiation oncology providers in California

Medicare billing

Part B allowed, 2024
$273,454
Medicare patients
422
Services billed
2,985

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dexamethasone11$325
Tamsulosin Hcl22$249

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Chico

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →